title: Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency.
abstract: In high-burden countries, Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine is administered in newborn to prevent severe Mycobacterium tuberculosis infection. Because life-threatening disseminated BCG disease may occur in children with primary immunodeficiency, vaccination strategy against tuberculosis should be redefined in non-high-burden countries. We report the case of a patient with X-linked severe combined immunodeficiency (SCID) who developed disseminated BCG disease, highlighting the specific strategies adopted.
authors: Pediatric Intensive Care Unit, Hospital Dona Estefânia, 1169-045 Lisboa, Portugal.
authors: Sílvia
authors: S
authors: Bacalhau
authors: Cristina
authors: C
authors: Freitas
authors: Rosalina
authors: R
authors: Valente
authors: Deolinda
authors: D
authors: Barata
authors: Conceição
authors: C
authors: Neves
authors: Katrin
authors: K
authors: Schäfer
authors: Annelie
authors: A
authors: Lubatschofski
authors: Ansgar
authors: A
authors: Schulz
authors: João Farela
authors: JF
authors: Neves